Page last updated: 2024-08-17

hydroxyproline and semaxinib

hydroxyproline has been researched along with semaxinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Feng, YL; Huang, XY; Li, WC; Li, YP; Liu, DS; Ou, XM; Wang, K; Wang, T; Wang, X; Wen, FQ; Zhang, SF	1

Other Studies

1 other study(ies) available for hydroxyproline and semaxinib

Article	Year
VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. International immunopharmacology, 2009, Volume: 9, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Flow Cytometry; Hydroxyproline; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pulmonary Fibrosis; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2009

Article

Year

VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.

International immunopharmacology, 2009, Volume: 9, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Flow Cytometry; Hydroxyproline; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pulmonary Fibrosis; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2009